Aguade-Gorgorio G, Anderson A, Sole R
iScience. 2024; 27(9):110699.
PMID: 39280631
PMC: 11402243.
DOI: 10.1016/j.isci.2024.110699.
Wang M, Scott J, Vladimirsky A
PLoS Comput Biol. 2024; 20(6):e1012165.
PMID: 38875286
PMC: 11210878.
DOI: 10.1371/journal.pcbi.1012165.
Del Pino Herrera A, Ferrall-Fairbanks M
Front Genet. 2024; 15:1383676.
PMID: 38873108
PMC: 11169904.
DOI: 10.3389/fgene.2024.1383676.
Akman T, Arendt L, Geisler J, Kristensen V, Frigessi A, Kohn-Luque A
Bull Math Biol. 2024; 86(4):42.
PMID: 38498130
PMC: 11310292.
DOI: 10.1007/s11538-023-01253-1.
Carels N, Sgariglia D, Vieira Junior M, Lima C, Goncalves Carneiro F, Silva G
Int J Mol Sci. 2023; 24(22).
PMID: 38003288
PMC: 10671768.
DOI: 10.3390/ijms242216098.
Strategies to Reduce Long-Term Drug Resistance by Considering Effects of Differential Selective Treatments.
Asnaashari T, Chang Y
Math Comput Oncol (2021). 2023; 13060:49-60.
PMID: 37342205
PMC: 10280777.
DOI: 10.1007/978-3-030-91241-3_5.
Effective dose window for containing tumor burden under tolerable level.
Masud M, Kim J, Kim E
NPJ Syst Biol Appl. 2023; 9(1):17.
PMID: 37221258
PMC: 10205748.
DOI: 10.1038/s41540-023-00279-4.
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation.
West J, Adler F, Gallaher J, Strobl M, Brady-Nicholls R, Brown J
Elife. 2023; 12.
PMID: 36952376
PMC: 10036119.
DOI: 10.7554/eLife.84263.
Smart Magnetic Drug Delivery Systems for the Treatment of Cancer.
Spoiala A, Ilie C, Motelica L, Ficai D, Semenescu A, Oprea O
Nanomaterials (Basel). 2023; 13(5).
PMID: 36903753
PMC: 10004758.
DOI: 10.3390/nano13050876.
Modeling cancer's ecological and evolutionary dynamics.
Bukkuri A, Pienta K, Hockett I, Austin R, Hammarlund E, Amend S
Med Oncol. 2023; 40(4):109.
PMID: 36853375
PMC: 9974726.
DOI: 10.1007/s12032-023-01968-0.
The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer.
Wolfl B, Te Rietmole H, Salvioli M, Kaznatcheev A, Thuijsman F, Brown J
Dyn Games Appl. 2022; 12(2):313-342.
PMID: 35601872
PMC: 9117378.
DOI: 10.1007/s13235-021-00397-w.
Combination treatment optimization using a pan-cancer pathway model.
Schmucker R, Farina G, Faeder J, Frohlich F, Saglam A, Sandholm T
PLoS Comput Biol. 2021; 17(12):e1009689.
PMID: 34962919
PMC: 8747684.
DOI: 10.1371/journal.pcbi.1009689.
Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer.
Bondarenko M, Le Grand M, Shaked Y, Raviv Z, Chapuisat G, Carrere C
Cancers (Basel). 2021; 13(9).
PMID: 34066944
PMC: 8125381.
DOI: 10.3390/cancers13092239.
A theoretical analysis of tumour containment.
Viossat Y, Noble R
Nat Ecol Evol. 2021; 5(6):826-835.
PMID: 33846605
PMC: 8967123.
DOI: 10.1038/s41559-021-01428-w.
Control Theory and Cancer Chemotherapy: How They Interact.
Lecca P
Front Bioeng Biotechnol. 2021; 8:621269.
PMID: 33520972
PMC: 7841331.
DOI: 10.3389/fbioe.2020.621269.
Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer.
Cunningham J, Thuijsman F, Peeters R, Viossat Y, Brown J, Gatenby R
PLoS One. 2020; 15(12):e0243386.
PMID: 33290430
PMC: 7723267.
DOI: 10.1371/journal.pone.0243386.
Turnover Modulates the Need for a Cost of Resistance in Adaptive Therapy.
Strobl M, West J, Viossat Y, Damaghi M, Robertson-Tessi M, Brown J
Cancer Res. 2020; 81(4):1135-1147.
PMID: 33172930
PMC: 8455086.
DOI: 10.1158/0008-5472.CAN-20-0806.
Cell plasticity in cancer cell populations.
Shen S, Clairambault J
F1000Res. 2020; 9.
PMID: 32595946
PMC: 7309415.
DOI: 10.12688/f1000research.24803.1.
Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory.
Gluzman M, Scott J, Vladimirsky A
Proc Biol Sci. 2020; 287(1925):20192454.
PMID: 32315588
PMC: 7211445.
DOI: 10.1098/rspb.2019.2454.
Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.
Greene J, Gevertz J, Sontag E
JCO Clin Cancer Inform. 2019; 3:1-20.
PMID: 30969799
PMC: 6873992.
DOI: 10.1200/CCI.18.00087.